Tibor Szarvas, Ph.D.
Affiliations: | 2008 | Semmelweis Egyetem, Hungary |
Area:
Oncology, Molecular BiologyGoogle:
"Tibor Szarvas"Parents
Sign in to add mentor| Ilona Kovalszky | grad student | 2008 | Semmelweis Egyetem | |
| (Hugyholyagrakok molekularis diagnosztikai es prognosztikai modszerei.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Tóth G, Sugár S, Pál D, et al. (2022) Glycosaminoglycan Analysis of FFPE Tissues from Prostate Cancer and Benign Prostate Hyperplasia Patients Reveals Altered Regulatory Functions and Independent Markers for Survival. Cancers. 14 |
| Olah C, Tschirdewahn S, Hoffmann MJ, et al. (2020) Soluble Syndecan-1 Levels Are Associated with Survival in Platinum-Treated Bladder Cancer Patients. Diagnostics (Basel, Switzerland). 10 |
| Hollósi P, Váncza L, Karászi K, et al. (2020) Syndecan-1 Promotes Hepatocyte-Like Differentiation of Hepatoma Cells Targeting Ets-1 and AP-1. Biomolecules. 10 |
| Hager T, Kraywinkel K, Szarvas T, et al. (2020) Urachal Cancer in Germany and the USA: An RKI/SEER Population-Based Comparison Study. Urologia Internationalis. 104: 1-7 |
| Nagy N, Reis H, Hadaschik B, et al. (2020) Prevalence of APC and PTEN Alterations in Urachal Cancer. Pathology Oncology Research : Por |
| Niedworok C, Kempkensteffen C, Eisenhardt A, et al. (2020) Serum and tissue syndecan-1 levels in renal cell carcinoma. Translational Andrology and Urology. 9: 1167-1176 |
| Kovács PT, Juhász D, Módos O, et al. (2020) Characteristics of bladder recurrence after radical nephroureterectomy in upper urinary tract cancer Orvosi Hetilap. 161: 881-888 |
| Szarvas T, Csizmarik A, Nagy N, et al. (2020) Molecular underpinnings of systemic treatment resistance in metastatic castration-resistant prostate cancer Orvosi Hetilap. 161: 813-820 |
| Szarvas T, Csizmarik A, Fazekas T, et al. (2020) Comprehensive analysis of serum chromogranin A and neuron-specific enolase levels in localized and castration-resistant prostate cancer. Bju International |
| Nini A, Hoffmann MJ, Lampignano R, et al. (2020) Evaluation of HER2 expression in urothelial carcinoma cells as a biomarker for circulating tumor cells. Cytometry. Part B, Clinical Cytometry |